← Browse by Condition
Medical Condition
fabry disease
Total Trials
2
Recruiting Now
2
Trial Phases
Various
NCT07187440
Recruiting
A Study of Agalsidase Alfa Enyzme Replacement Therapy in Chinese Children and Adults With Fabry Disease
Enrollment
200 pts
Location
China
Sponsor
Takeda
NCT06065852
Recruiting
National Registry of Rare Kidney Diseases
Enrollment
35,000 pts
Location
United Kingdom
Sponsor
UK Kidney Association